[Technological innovation in diabetes: is it suitable for everyone and at what price?].
Tools for monitoring diabetes such as glucose testing devices, continuous glucose monitoring and telemedicine in particular, those for treating the disease such as insulin pens and pumps, or the "artificial pancreas", are constantly improving thanks to technological advances, which also concern preventative treatments. However, these new techniques are particularly costly. They also require considerable investment from the multidisciplinary nursing team in terms of therapeutic patient education.
Polyclinique de médecine interne, hôpital Saint-Louis, groupe hospitalier, Lariboisière Saint-Louis, AP-HP, Paris. j-pierre.sauvanet@orange.fr
Jean-Pierre
JP
Sauvanet
D003920:Diabetes Mellitus / Q000097:blood* / Q000628:therapy*; D016503:Drug Delivery Systems; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems; D016381:Islets of Langerhans Transplantation; D019397:Pancreas, Artificial; D017216:Telemedicine
D007004:Hypoglycemic Agents; D007328:Insulin